IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 348 filers reported holding IONIS PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,418,149 | -3.7% | 229,677 | -12.9% | 0.01% | 0.0% |
| Q2 2023 | $10,813,826 | +316.7% | 263,559 | +263.0% | 0.01% | +500.0% |
| Q1 2023 | $2,595,153 | -15.9% | 72,612 | -12.0% | 0.00% | -50.0% |
| Q4 2022 | $3,084,195 | -21.8% | 82,523 | -7.4% | 0.00% | -33.3% |
| Q3 2022 | $3,944,959 | +12.7% | 89,096 | -4.4% | 0.00% | +50.0% |
| Q2 2022 | $3,498,925 | +30.0% | 93,214 | +23.8% | 0.00% | 0.0% |
| Q1 2022 | $2,692,441 | +1158.2% | 75,298 | +2025.3% | 0.00% | – |
| Q4 2019 | $214,000 | -0.9% | 3,543 | -3.0% | 0.00% | – |
| Q3 2019 | $216,000 | -3.6% | 3,651 | +4.9% | 0.00% | – |
| Q2 2019 | $224,000 | -10.8% | 3,479 | +12.7% | 0.00% | – |
| Q1 2019 | $251,000 | +54.9% | 3,087 | -20.4% | 0.00% | – |
| Q2 2018 | $162,000 | -6.9% | 3,876 | -1.5% | 0.00% | – |
| Q1 2018 | $174,000 | -11.7% | 3,934 | +0.3% | 0.00% | – |
| Q4 2017 | $197,000 | -3.9% | 3,923 | -2.6% | 0.00% | – |
| Q3 2017 | $205,000 | +7.9% | 4,027 | +7.6% | 0.00% | – |
| Q2 2017 | $190,000 | +37.7% | 3,744 | +9.1% | 0.00% | – |
| Q1 2017 | $138,000 | -15.9% | 3,433 | 0.0% | 0.00% | – |
| Q4 2016 | $164,000 | +30.2% | 3,433 | 0.0% | 0.00% | – |
| Q3 2016 | $126,000 | +24.8% | 3,433 | -20.1% | 0.00% | – |
| Q2 2016 | $101,000 | -38.0% | 4,295 | +2.0% | 0.00% | – |
| Q1 2016 | $163,000 | -35.8% | 4,212 | +2.7% | 0.00% | – |
| Q4 2015 | $254,000 | – | 4,102 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,046 | $126,557 | 6.89% |
| M28 Capital Management LP | 126,300 | $4,513,962 | 5.10% |
| Bellevue Group AG | 9,511,900 | $339,955,306 | 4.93% |
| Deep Track Capital, LP | 2,834,069 | $101,289,626 | 4.16% |
| BVF INC/IL | 2,560,761 | $91,521,598 | 3.35% |
| Sicart Associates LLC | 210,698 | $7,530,347 | 2.93% |
| Privium Fund Management B.V. | 182,773 | $6,532,307 | 2.19% |
| Camber Capital Management LP | 1,925,000 | $68,800 | 2.12% |
| Orbimed Advisors | 2,124,500 | $75,929,630 | 1.49% |
| SECTOR GAMMA AS | 146,441 | $5,233,801 | 1.27% |